A 52-year-old man from Delhi presents with a 3.5 mm thick melanoma on his back with no ulceration and a mitotic rate of 2/mm². Sentinel lymph node biopsy is negative. Which feature best distinguishes his stage from a patient with identical tumor characteristics but with microscopic ulceration?

Explanation

## Impact of Ulceration on Melanoma Stage: 3.5 mm Primary Tumor ### Clinical Scenario Analysis **Key Point:** Ulceration acts as a **stage-upgrading factor** independent of thickness and mitotic rate. A 3.5 mm melanoma without ulceration is Stage IIA; the same tumor with ulceration becomes Stage IIB. ### Staging Breakdown for This Patient | Feature | Non-Ulcerated | Ulcerated | |---------|----------------|----------| | **Thickness** | 3.5 mm | 3.5 mm | | **Mitotic rate** | 2/mm² | 2/mm² | | **Ulceration** | Absent | Present | | **SLN status** | Negative | Negative | | **AJCC Stage** | **IIA** | **IIB** | | **5-year survival** | ~80% | ~65% | ### Why Ulceration Upgrades the Stage **High-Yield:** In AJCC 8th edition, **ulceration is an independent adverse prognostic factor** that shifts a melanoma up one stage within the localized (Stage I–II) category: 1. **Without ulceration:** Thickness 2.01–4.0 mm → Stage IIA 2. **With ulceration:** Same thickness → Stage IIB (one stage higher) This reflects the significantly worse prognosis conferred by ulceration, even when thickness and mitotic rate are identical. ### Why Not Stage IIIA? **Clinical Pearl:** Stage IIIA requires **regional lymph node involvement** (sentinel node positivity, micrometastases, or clinically evident nodal disease). This patient's negative SLN biopsy keeps him in Stage II regardless of ulceration status. Ulceration does not create Stage III disease by itself; nodal involvement does. ### Mnemonic **Mnemonic: "U-BUMP"** — **U**lceration **B**umps you **U**p one **M**ajor **P**rognostic stage. [cite:AJCC Cancer Staging Manual 8th Edition; Gershenwald et al. J Clin Oncol 2017]